U.S., Aug. 20 -- An application to own the trademark for 'RITE3' has been filed on Aug. 30, 2024.
Owner(s):
SEED Therapeutics US, Inc.; 411 Swedeland Road, Suite #1000, , PENNSYLVANIA
Goods and/or Services:
For: drug discovery, pharmaceutical drug development, and drug validation services in the field of targeted disease-causing or disease-associated protein degradation; pharmaceutical research and development services, in particular for identifying ubiquitin ligases; providing medical research and scientific information related to ubiquitin ligase identification and targeted disease-causing or disease-associated protein degradation in the fields of pharmaceuticals, biological life sciences, chemistry, biochemistry, biotechnology, and c...